Navigation Links
Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.
Date:11/16/2007

urities Litigation Reform Act of 1995, including statements relating to the company's plans, future actions and expected timelines. Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including obtaining regulatory approvals, inaccurate assumptions, market forces, economic factors, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details of these and other risks and uncertainties that may impact forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A, "Risk Factors" in the Schering-Plough's third quarter 2007 10-Q.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
2. Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings
3. Schering-Plough Reports Financial Results for Third Quarter of 2007
4. Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment
5. Schering-Plough Reports U.S. District Court for District of Massachusetts Finds No Liability for Subsidiary in AWP Case
6. Schering-Plough to Webcast CFO Robert J. Bertolinis Presentation at 2007 Credit Suisse Health Care Conference
7. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
8. DaVita Receives Civil Complaint
9. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
10. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
11. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...h Care Reform Bill ,, Critical legislation wo...Americans ,, CHICAGO, Nov. 7 /PRNewswire-USNew...entatives passed by a vote of 220-215, critical he... Medicare for seniors and end discrimination by in...s out of affordable health coverage. ,, The A...
(Date:11/7/2009)...swire/ -- Karen Ignagni, President and CEO of Amer...following statement today on House passage of H.R....hensive health care reform, and we have contribute...aul of how health insurance is provided. Earlier t...tion of pre-existing condition exclusions, no long...
(Date:11/7/2009)... Cook (GA), Louis J. Goodman (TX), Palmer P. Jones..., Nov. 7 The American M...cal society executive leaders with achievement awa...ideals of the medical profession. The awards were ...eeting in Houston. ,, (Logo: http://www.news...
(Date:11/7/2009)...responsibility to vigorously oppose abortion in he...ASHINGTON, Nov. 7 Am...the following statement on the news that Cardinal ...Affordable Health Care for America Act (H.R. 3962)...for abortion is voted upon. ,, "Our Catholic b...
(Date:11/7/2009)...ciety of America (PRSA) will bestow the distinguis...vice president of Brand Strategy, Communications a... at PRSA,s 2009 International Conference in San Di... Fellows is one of the profession,s highest indivi...ow PRSA, and 2009 chair of the College of Fellows....
Breaking Medicine News(10 mins):Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Medical Society Executives 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3
... lesser mortals, with a lower life expectancy, unt...for the fair-sex. //In 2006 especially, there appe...women the world over, so much so that they seem to...tries, with lifestyles and smoking patterns being ...
...st 50 cattle are reported to have died in Madhya P...id Saturday.// Anthrax, an acute infectious d...lus anthracis, was first reported in the state in ...wer vertebrates like cattle, sheep, goats, camels,...
...ssengers on long haul flights sporting sunglasses,... for cover nor are they wearing it to enhance thei...e utility benefits and perhaps will score very hig... that sunglasses can help reduce jet lag. Now pass...
...tech firm TeGenero, the drugs company behind the c... its 12-page document prepared by Parexel. //This ...sly harm the immune system. The clinical trial le...ble effect of the drug was cytokine release. This ...
...eople need up to six times as much sunlight as tho...tamin D, says a new study// . Researchers at...r-skinned people need over four minutes in the sum...hing also depends on geography and the amount of s...
... Kerala food items, recipe displays and traditiona... three-day Spicy// Heritage of Kerala food festiva...ble to attract so many tourists because of the var...r of Tourism and Culture Ambika Soni said inaugura...
Other Medicine News:
(Date:11/6/2009)...e-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC ...ously approved reverse split of its common stock w... Nov. 9, 2009 on a 1-for-15 split-adjusted basis. ...er the new symbol OXBT. The stock also will have a...omes effective. ,, "This reverse split was over...
(Date:11/6/2009)...wswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(&#...t is developing and marketing Levulan(®) Phot...on patients with common skin conditions, announced...icer, will present a corporate overview at the Mer... November 10, 2009 at 10:00 a.m. ET at the Hotel S...
(Date:11/6/2009)...wire/ -- Kaiser Foundation Health Plan, Inc., Kais...iaries reported today a combined total operating r...ember 30, 2009, compared to $10.2 billion in the t... third quarter was $336 million, compared to $307 ...-operating income was $233 million in the third qu...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 1Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 2Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 3BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 1BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 2BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 3BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 4BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 5BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 6BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 7OMG Announces Special Event 3A Terminology Services Information Day 60441 1OMG Announces Special Event 3A Terminology Services Information Day 60441 2OMG Announces Special Event 3A Terminology Services Information Day 60441 3
...er Concordance Compared to FISH and... Include Reporting for HER2 Gene Expression in All... of 2008 -, REDWOOD CITY, Calif., Sept. 6 Genomi...ults from two studies demonstrating,that quantitat...d by the,company,s Oncotype DX(R) breast cancer as...
...Amex: CVM ) announced today that it presented new...ference on Immunogenicity in Amsterdam. The data,p...ident of Research,Cellular Immunology of CEL-SCI, ...ne CEL-2000 prevents or retards the permanent tiss...mal model of the disease. These new,findings furth...
Other Medicine Technology:Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 2Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 3Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 4Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients 5Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4
Gellhorn Pessary
Ring Pessary
Pyramis
...female urinary stress incontinence (SUI) with a mi...ic (BioArcTM SP) or a transobturator (BioArcTM TO)...em combining synthetic and biologic materials. It ...BioArc utilizes a polypropylene mesh for fixation ...
Medicine Products: